Henry M. Jackson Foundation for the Advancement of Military Medicine

Advancing Military Medicine

Search Results - assay

2 Results Sort By:
Diagnostic Tool for High-grade Serous Ovarian Cancer - (HJF 616-21)
Researchers at HJF, Inova Fairfax Hospital (IFH), and the Peter MacCallum Cancer Center (PMCC) have identified orthogonal protein and transcript-based biomarkers correlating with Homologous Recombination Deficiency (HRD). This may lead to a companion clinical diagnostic assay to prioritize High-Grade Serous Ovarian Cancer (HGSOC) patients for targeted...
Published: 12/12/2024   |   Updated: 12/12/2024   |   Inventor(s): Nicholas Bateman, Tamara Abulez, Thomas Conrads, George Larry Maxwell, Dale Garsed, David Bowtell, Ahwan Pandey
Keywords(s): Assay, Biomarker Assay, Companion Diagnostic, DDR, DNA Damage Repair, HGSOC, High-Grade Serous Ovarian Carcinoma, Ovarian Cancer, PARP Inhibitors
Category(s): Diagnostics, Therapeutic
Immunogens and Vaccine Components Against HIV - (HJF 630-22)
Henry M. Jackson Foundation (HJF) researchers have developed a novel vaccine strategy against HIV-1. These vaccine candidates are designed to elicit broadly neutralizing antibodies that could protect against a wide variety of HIV strains. Applications and Advantages Novel vaccine design approach that emulates the diversity observed in HIV-1 infections...
Published: 11/6/2024   |   Updated: 2/7/2024   |   Inventor(s): Morgane Rolland, Eric Lewitus, Hongjun Bai
Keywords(s): Antibody, Assay, bnAbs, CD4, Env, HIV, Vaccines
Category(s): Vaccine, Therapeutic